Biotech firm treats first patient in Western world with CRISPR technique for blood disease
A Switzerland-based startup called CRISPR Therapeutics just used gene-editing name to treat someone with the blood disease beta thalassemia. It marks the first time CRISPR gene editing has been used in a Western clinic.